Literature DB >> 9934916

Occurrence of withdrawal in critically ill sedated children.

L Fonsmark1, Y H Rasmussen, P Carl.   

Abstract

OBJECTIVES: To record the number of children with withdrawal symptoms after the administration of sedatives for mechanical ventilation, and to discuss the possible connection with the administration of midazolam.
DESIGN: Retrospective data collection from case records and charts.
SETTING: Medical and surgical intensive care unit (ICU) in a university hospital. PATIENTS: Children 6 months to 14 yrs of age who required sedation for mechanical ventilation (n = 40).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Kind and amount of sedatives and analgesics, duration of administration, and occurrence of withdrawal symptoms. The frequency of withdrawal symptoms was 35% (14/40) of the sedated children. A total dose of midazolam of >60 mg/kg was strongly significantly associated with occurrence of withdrawal. Statistical analysis to determine the occurrence of withdrawal associated with the administration of morphine was not possible.
CONCLUSIONS: Signs and symptoms of a withdrawal reaction were observed in several children. The occurrence of withdrawal was statistically related to high doses of midazolam, but it was not possible to determine the influence of morphine. If large doses of midazolam and opioids have been administered, there may be justification for reducing the dose gradually instead of abruptly, or using longer-acting benzodiazepines or opioids on discontinuation of sedation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934916     DOI: 10.1097/00003246-199901000-00052

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  33 in total

1.  Dexmedetomidine: Are There Going to be Issues with Prolonged Administration?

Authors:  Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

Review 2.  Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model.

Authors:  Kaitlin M Best; Joseph I Boullata; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2015-02       Impact factor: 3.624

3.  Use of methadone for opioid weaning in children: prescribing practices and trends.

Authors:  Kazim Giby; Régis Vaillancourt; Nisha Varughese; Christina Vadeboncoeur; Annie Pouliot
Journal:  Can J Hosp Pharm       Date:  2014-03

4.  Calcium channel blocker attenuated opioid withdrawal syndrome.

Authors:  Tatsutoshi Shimatani; Hiroshi Adachi; Hiroyuki Mihashi; Noriko Usumoto; Kohei Yoshimoto; Katsuhiko Ayukawa
Journal:  Acute Med Surg       Date:  2014-08-08

5.  Periaqueductal gray neuroplasticity following chronic morphine varies with age: role of oxidative stress.

Authors:  D Bajic; C B Berde; K G Commons
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

6.  Morphine-enhanced apoptosis in selective brain regions of neonatal rats.

Authors:  Dusica Bajic; Kathryn G Commons; Sulpicio G Soriano
Journal:  Int J Dev Neurosci       Date:  2013-03-07       Impact factor: 2.457

7.  Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation.

Authors:  E D Wildschut; M N Hanekamp; N J Vet; R J Houmes; M J Ahsman; R A A Mathot; S N de Wildt; D Tibboel
Journal:  Intensive Care Med       Date:  2010-05-28       Impact factor: 17.440

8.  Use of oral clonidine for sedation in ventilated paediatric intensive care patients.

Authors:  Sara Arenas-López; Shelley Riphagen; Shane M Tibby; Andrew Durward; Steve Tomlin; Graham Davies; Ian A Murdoch
Journal:  Intensive Care Med       Date:  2004-06-10       Impact factor: 17.440

9.  Long-term behavioral effects in a rat model of prolonged postnatal morphine exposure.

Authors:  Michael M Craig; Dusica Bajic
Journal:  Behav Neurosci       Date:  2015-07-27       Impact factor: 1.912

Review 10.  Optimal sedation in pediatric intensive care patients: a systematic review.

Authors:  Nienke J Vet; Erwin Ista; Saskia N de Wildt; Monique van Dijk; Dick Tibboel; Matthijs de Hoog
Journal:  Intensive Care Med       Date:  2013-06-19       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.